Abacus Life, a pioneering alternative asset manager specializing in longevity and actuarial technology, and Lorisco Life, a health prediction company using modern proteomics and machine learning to accurately forecast health events, today announced a new partnership and product launch to revolutionize longevity-based health prediction and actuarial technology.
The Lorisco PREADISAN risk score is a novel assessment and planning tool that generates individualized insights beyond traditional statistics-based life expectancy opinions. The PREADISAN risk score introduces blood-based proteomic biomarker analysis coupled with clinically driven artificial intelligence (AI) models that assess mortality risks. The PREADISAN risk score is a first of its kind tool that integrates biological insights with the assessment of mortality risk over time.
Abacus continues to develop and shape the future of technology in life settlements, longevity and actuarial technology. This partnership provides customized financial offerings for users based on Lorisco’s cutting-edge health prediction platform. Abacus’ leading capabilities are further enhanced with the launch of PREADISAN, a risk score forecasting longevity and health outcomes with unprecedented personalization. Lorisco’s proprietary machine learning algorithms use health risk models that incorporate modern proteomic markers on top of traditional actuarial factors, together enabling Abacus to offer bespoke solutions tailored to the client.
“We are proud to be partnering with Abacus Life to enable how health predictions are customized for end users through proteomics and machine learning,” said Howard Sams, Lorisco Life Chief Executive Officer. “The PREADISAN risk score enables the Abacus team to offer an unprecedented level of tailored solutions for their clients.”
“We are proud to enable a more personalized approach to longevity and actuarial technology for our partners and clients,” stated Jay Jackson, Abacus Chairman and Chief Executive Officer. “PREADISAN forecasts will further aid the focus of longevity and health in the future of financial planning and life settlements.”
Abacus will apply the risk scores to life and financial planning to design better financial products and allocations to their clients. Clients will also obtain more customized retirement planning and risk management insights from Abacus.
